药学与临床研究
藥學與臨床研究
약학여림상연구
PHARMACEUTICAL AND CLINICAL RESEARCH
2015年
2期
185-187
,共3页
前列地尔%机械通气%呼吸机相关性肺损伤
前列地爾%機械通氣%呼吸機相關性肺損傷
전렬지이%궤계통기%호흡궤상관성폐손상
Alprostadil%Mechanical Ventilation%Ventilator induced lung injury
目的:探讨前列地尔治疗呼吸机相关性肺损伤的临床疗效。方法:选择79例呼吸机相关性肺损伤患者,随机分为前列地尔治疗组(n=40)和对照组(n=39),两组患者均在常规积极治疗原发病的基础上采用肺保护性机械通气,治疗组在常规治疗基础上静脉泵注前列地尔10μg,2次/d,共治疗7天。观察两组的临床疗效,呼吸功能指标及炎性因子水平的变化。结果:治疗组与对照组在治疗前各项指标无差异。治疗后治疗组在总有效率、氧合指数、呼吸指数、APACHEⅡ评分、TNF-α、IL-1β、IL-6、IL-8等指标的检测上均显著优于对照组。结论:前列地尔可显著改善机械通气患者呼吸机相关性肺损伤的临床状况。
目的:探討前列地爾治療呼吸機相關性肺損傷的臨床療效。方法:選擇79例呼吸機相關性肺損傷患者,隨機分為前列地爾治療組(n=40)和對照組(n=39),兩組患者均在常規積極治療原髮病的基礎上採用肺保護性機械通氣,治療組在常規治療基礎上靜脈泵註前列地爾10μg,2次/d,共治療7天。觀察兩組的臨床療效,呼吸功能指標及炎性因子水平的變化。結果:治療組與對照組在治療前各項指標無差異。治療後治療組在總有效率、氧閤指數、呼吸指數、APACHEⅡ評分、TNF-α、IL-1β、IL-6、IL-8等指標的檢測上均顯著優于對照組。結論:前列地爾可顯著改善機械通氣患者呼吸機相關性肺損傷的臨床狀況。
목적:탐토전렬지이치료호흡궤상관성폐손상적림상료효。방법:선택79례호흡궤상관성폐손상환자,수궤분위전렬지이치료조(n=40)화대조조(n=39),량조환자균재상규적겁치료원발병적기출상채용폐보호성궤계통기,치료조재상규치료기출상정맥빙주전렬지이10μg,2차/d,공치료7천。관찰량조적림상료효,호흡공능지표급염성인자수평적변화。결과:치료조여대조조재치료전각항지표무차이。치료후치료조재총유효솔、양합지수、호흡지수、APACHEⅡ평분、TNF-α、IL-1β、IL-6、IL-8등지표적검측상균현저우우대조조。결론:전렬지이가현저개선궤계통기환자호흡궤상관성폐손상적림상상황。
Objective: To observe the effect of alprostadil in the treatment of ventilator induced lung injury (VILI). Methods: A total of 79 patients with ventilator induced lung injury were selected and randomly divided into treatment group (n=40) and control group (n=39). On the basis of treatment of the primary disease, the patients of the treatment group were intravenously pumped with alprostadil 10 μg, twice per day for 7 d. Curative effects, respiratory function parameters and inflammatory factors were observed to evaluate the effects of the 2 groups. Results: The parameters of the 2 groups before treatment had no difference. After 7 days treatment, the treatment group was significantly better than the control group in the parameters of the total effective rate, oxygenation index, spiro-index, APACHEⅡ scores, TNF-α, IL-1β, IL-6 and IL-8. Conclution:Alprostadil significantly improves the clinical conditions of patients with ventilator induced lung injury.